Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Builds a Chem-Bio Data Spreadsheet for GSK

SAN DIEGO, Oct. 25 — Accelrys and GlaxoSmithKline announced on Thursday that they have been in collaboration to produce a so-called “Hits and Leads Chemically Aware Spreadsheet” to enable GSK scientists to access, analyze, and visualize vast amounts of chemical and biological data stored in GSK’s R&D databases.

The technology is based on Accelrys’s Accord Grid Control, a tool for displaying multiple structures and reactions, as well as other data, in a grid format. The Grid Control was used as the basis of the data query and visualization tools and was interfaced to tools developed by GSK for uniting their databases.

Slava Budin-Jones, program manager at GSK said in a statement that Accelrys responded quickly to GSK’s request to work on site to jointly develop the initial prototype. Jeremy Potter, product manager for developer tools at Accelrys, said that the Accord Grid Control gives developers the ability to handle groups of structures and data with flexibility within one component.

Accelrys is a wholly-owned subsidiary of Pharmacopeia.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.